355 related articles for article (PubMed ID: 3959124)
1. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat.
Eigenberg DA; Bozigian HP; Carter DE; Sipes IG
J Toxicol Environ Health; 1986; 17(4):445-56. PubMed ID: 3959124
[TBL] [Abstract][Full Text] [Related]
2. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
3. Biochemical studies on phthalic esters. IV. Metabolism of diheptyl phthalate in rats.
Sato M; Adachi T; Tanaka A; Yamaha T
Drug Metab Dispos; 1984; 12(4):517-22. PubMed ID: 6148222
[TBL] [Abstract][Full Text] [Related]
4. Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of benzyl butyl phthalate and its metabolites, monobenzyl phthalate and monobutyl phthalate, in rat plasma, urine, and various tissues collected from a toxicokinetic study.
Kim MG; Kim TH; Shin BS; Lee YB; Lee JB; Choi HG; Lee Y; Yoo SD
Anal Bioanal Chem; 2015 Sep; 407(24):7391-400. PubMed ID: 26168976
[TBL] [Abstract][Full Text] [Related]
5. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
6. Disposition of 9-aminoacridine in rats dosed orally or intravenously and in monkeys dosed topically.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1985; 15(6):789-99. PubMed ID: 4057283
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicological evaluation of phthalate diesters and metabolites in Sprague-Dawley male rats for risk assessment.
Kwack SJ; Kim KB; Kim HS; Lee BM
J Toxicol Environ Health A; 2009; 72(21-22):1446-54. PubMed ID: 20077217
[TBL] [Abstract][Full Text] [Related]
8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
9. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat.
Chu I; Villeneuve DC; Secours V; Franklin C; Rock G; Viau A
Drug Metab Dispos; 1978; 6(2):146-9. PubMed ID: 26529
[TBL] [Abstract][Full Text] [Related]
12. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
13. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
14. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
16. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
17. Disposition of 2-(2-quinolyl)-1,3-indandione (D. C. yellow #11) in rats dosed orally or intravenously.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1988; 23(3):385-93. PubMed ID: 3351983
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
19. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
20. Disposition of benzo(f)quinoline in male rats.
Birnbaum LS; Johnson L
Drug Metab Dispos; 1985; 13(1):18-24. PubMed ID: 2858371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
